StonvexLoading…
StonvexStonvexStonvexCore line items from CMRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $86.84M | $342.35M | $252.83M | $166.80M |
Operating Income | $5.77M | $-16.22M | $-9.63M | $-9.20M |
Net Income | $3.73M | $-19.34M | $-10.98M | $-8.38M |
EPS (Diluted) | $0.05 | $-0.24 | $-0.14 | $-0.11 |
Total Assets | $324.26M | $308.79M | $309.46M | $302.53M |
Total Liabilities | $277.38M | $269.44M | $266.63M | $263.77M |
Cash & Equivalents | $57.20M | $44.26M | $49.91M | $46.27M |
Free Cash Flow OCF − CapEx | $14.09M | $16.89M | $19.07M | $11.48M |
Shares Outstanding | 82.32M | 81.65M | 79.91M | 79.48M |